We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+12.63%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$638M
AUM Growth
+$36.1M
Cap. Flow
-$31.1M
Cap. Flow %
-4.87%
Top 10 Hldgs %
67.85%
Holding
37
New
5
Increased
15
Reduced
10
Closed
6

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$14.7M
2
A icon
Agilent Technologies
A
+$14.1M
3
BIIB icon
Biogen
BIIB
+$12.4M
4
PRGO icon
Perrigo
PRGO
+$8.54M
5
SHPG
Shire pic
SHPG
+$5.79M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$23.4M
2
LLY icon
Eli Lilly
LLY
+$16.8M
3
MRK icon
Merck
MRK
+$12.2M
4
BMY icon
Bristol-Myers Squibb
BMY
+$10.8M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.83M

Sector Composition

Rank Sector Weight
1 Healthcare 98.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARRY
26
DELISTED
Array Biopharma Inc
ARRY
$5.08M 0.8%
+334,100
New +$5.12M
ALNY icon
27
Alnylam Pharmaceuticals
ALNY
$36.4B
$3.98M 0.62%
45,437
+12,937
+40% +$1.3M
SGMO
28
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.63M 0.41%
154,960
+8,960
+6% +$136K
RARE icon
29
Ultragenyx Pharmaceutical
RARE
$2.81B
$2.24M 0.35%
29,368
-38,647
-57% -$3.14M
ONCE
30
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.84M 0.29%
33,814
+2,214
+7% +$151K
LLY icon
31
Eli Lilly
LLY
$1.02T
$1.47M 0.23%
13,650
-167,991
-92% -$16.8M
BLUE
32
DELISTED
bluebird bio
BLUE
– –
-1,312
Closed -$2.67M
IRWD icon
33
Ironwood Pharmaceuticals
IRWD
$634M
– –
-506,077
Closed -$8.1M
LH icon
34
Labcorp
LH
$23.1B
– –
-60,125
Closed -$9.27M
REGN icon
35
Regeneron Pharmaceuticals
REGN
$70.5B
– –
-28,500
Closed -$9.83M
RGNX icon
36
Regenxbio
RGNX
$557M
– –
-10,000
Closed -$718K
THC icon
37
Tenet Healthcare
THC
$16.7B
– –
-90,503
Closed -$3.04M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2018 Portfolio in Review

As of Q3 2018, Sector Gamma AS held 37 positions worth $638M, up 6% from $602M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Sector Gamma AS withdrew a net $31.1M in Q3 2018, closing 6 positions and reducing 10 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $9.83M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Incyte worth $14.8M.

  • Sector Gamma AS's largest Q3 2018 buy was Incyte: 213,764 shares worth $14.8M.
  • Sector Gamma AS added most to Perrigo in Q3 2018, an estimated $8.54M increase.
  • Sector Gamma AS's biggest Q3 2018 reduction was AstraZeneca, cutting an estimated $23.4M.
  • Sector Gamma AS fully exited Regeneron Pharmaceuticals in Q3 2018, selling an estimated $9.83M.
  • Sector Gamma AS's ten largest holdings make up 68% of its $638M portfolio in Q3 2018.
  • Sector Gamma AS opened 5 new positions and closed 6 in Q3 2018.
  • Sector Gamma AS's portfolio value rose 6% quarter-over-quarter to $638M.

Based on Sector Gamma AS's 13F filing for Q3 2018, filed 8 Nov 2018.